AHNAK and Inflammatory Markers Predict Poor Survival in Laryngeal Carcinoma

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Dumitru, Claudia A ^a   Bankfalvi, Agnes ^a   Gu, Xiang ^a   Zeidler, Reinhard ^b   Brandau, Sven ^a   Lang, Stephan ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; MACROPHAGE MIGRATION INHIBITION FACTOR; PROTEIN AHNAK; UNCLASSIFIED DRUG;

ARTICLE; CANCER PROGNOSIS; CANCER SURVIVAL; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; INFLAMMATION; LARYNX CARCINOMA; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL; OVERALL SURVIVAL; PROTEIN EXPRESSION; RISK FACTOR;

ANTIGENS, CD; CELL ADHESION MOLECULES; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GPI-LINKED PROTEINS; HUMANS; INFLAMMATION; LARYNGEAL NEOPLASMS; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MALE; MEMBRANE PROTEINS; MULTIVARIATE ANALYSIS; NEOPLASM PROTEINS; PROGNOSIS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84873596512     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0056420     Document Type: Article

References (29)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, et al. (2007) Cancer statistics, 2007. CA Cancer J Clin 57: 43-66.
2. Choong N, Vokes E, (2008) Expanding role of the medical oncologist in the management of head and neck cancer. CA Cancer J Clin 58: 32-53.
3. Shtivelman E, Cohen FE, Bishop JM, (1992) A human gene (AHNAK) encoding an unusually large protein with a 1.2-microns polyionic rod structure. Proc Natl Acad Sci U S A 89: 5472-5476.
4. Shtivelman E, Bishop JM, (1993) The human gene AHNAK encodes a large phosphoprotein located primarily in the nucleus. The Journal of cell biology 120: 625-630.
5. Borgonovo B, Cocucci E, Racchetti G, Podini P, Bachi A, et al. (2002) Regulated exocytosis: a novel, widely expressed system. Nature cell biology 4: 955-962.
6. Masunaga T, Shimizu H, Ishiko A, Fujiwara T, Hashimoto T, et al. (1995) Desmoyokin/AHNAK protein localizes to the non-desmosomal keratinocyte cell surface of human epidermis. J Invest Dermatol 104: 941-945.
7. Hashimoto T, Gamou S, Shimizu N, Kitajima Y, Nishikawa T, (1995) Regulation of translocation of the desmoyokin/AHNAK protein to the plasma membrane in keratinocytes by protein kinase C. Exp Cell Res 217: 258-266.
8. Sussman J, Stokoe D, Ossina N, Shtivelman E, (2001) Protein kinase B phosphorylates AHNAK and regulates its subcellular localization. The Journal of cell biology 154: 1019-1030.
9. Haase H, Podzuweit T, Lutsch G, Hohaus A, Kostka S, et al. (1999) Signaling from beta-adrenoceptor to L-type calcium channel: identification of a novel cardiac protein kinase A target possessing similarities to AHNAK. FASEB J 13: 2161-2172.
10. Gentil BJ, Delphin C, Mbele GO, Deloulme JC, Ferro M, et al. (2001) The giant protein AHNAK is a specific target for the calcium- and zinc-binding S100B protein: potential implications for Ca2+ homeostasis regulation by S100B. J Biol Chem 276: 23253-23261.
11. Shankar J, Messenberg A, Chan J, Underhill TM, Foster LJ, et al. (2010) Pseudopodial actin dynamics control epithelial-mesenchymal transition in metastatic cancer cells. Cancer Res 70: 3780-3790.
12. Tanaka M, Jin G, Yamazaki Y, Takahara T, Takuwa M, et al. (2008) Identification of candidate cooperative genes of the Apc mutation in transformation of the colon epithelial cell by retroviral insertional mutagenesis. Cancer Sci 99: 979-985.
13. Coussens LM, Werb Z, (2002) Inflammation and cancer. Nature 420: 860-867.
14. Nozawa H, Chiu C, Hanahan D, (2006) Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis. Proc Natl Acad Sci U S A 103: 12493-12498.
15. Jablonska J, Leschner S, Westphal K, Lienenklaus S, Weiss S, (2010) Neutrophils responsive to endogenous IFN-beta regulate tumor angiogenesis and growth in a mouse tumor model. J Clin Invest 120: 1151-1164.
16. Bekes EM, Schweighofer B, Kupriyanova TA, Zajac E, Ardi VC, et al. (2011) Tumor-recruited neutrophils and neutrophil TIMP-free MMP-9 regulate coordinately the levels of tumor angiogenesis and efficiency of malignant cell intravasation. Am J Pathol 179: 1455-1470.
17. Kuang DM, Zhao Q, Wu Y, Peng C, Wang J, et al. (2011) Peritumoral neutrophils link inflammatory response to disease progression by fostering angiogenesis in hepatocellular carcinoma. J Hepatol 54: 948-955.
18. Gregory AD, Houghton AM, (2011) Tumor-associated neutrophils: new targets for cancer therapy. Cancer Res 71: 2411-2416.
19. Dumitru CA, Moses K, Trellakis S, Lang S, Brandau S, (2012) Neutrophils and granulocytic myeloid-derived suppressor cells: immunophenotyping, cell biology and clinical relevance in human oncology. Cancer Immunol Immunother 61: 1155-1167.
20. Trellakis S, Bruderek K, Dumitru CA, Gholaman H, Gu X, et al. (2011) Polymorphonuclear granulocytes in human head and neck cancer: Enhanced inflammatory activity, modulation by cancer cells and expansion in advanced disease. Int J Cancer 129: 2183-2193.
21. Dumitru CA, Gholaman H, Trellakis S, Bruderek K, Dominas N, et al. (2011) Tumor-derived macrophage migration inhibitory factor modulates the biology of head and neck cancer cells via neutrophil activation. Int J Cancer 129: 859-869.
22. Dumitru CA, Fechner MK, Hoffmann TK, Lang S, Brandau S, (2012) A novel p38-MAPK signaling axis modulates neutrophil biology in head and neck cancer. J Leukoc Biol 91: 591-598.
23. Lin WW, Karin M, (2007) A cytokine-mediated link between innate immunity, inflammation, and cancer. J Clin Invest 117: 1175-1183.
24. Bucala R, Donnelly SC, (2007) Macrophage migration inhibitory factor: a probable link between inflammation and cancer. Immunity 26: 281-285.
25. Grieb G, Merk M, Bernhagen J, Bucala R, (2010) Macrophage migration inhibitory factor (MIF): a promising biomarker. Drug News Perspect 23: 257-264.
26. Rauch J, Ahlemann M, Schaffrik M, Mack B, Ertongur S, et al. (2004) Allogenic antibody-mediated identification of head and neck cancer antigens. Biochem Biophys Res Commun 323: 156-162.
27. Leong S, Nunez AC, Lin MZ, Crossett B, Christopherson RI, et al. (2012) iTRAQ-Based Proteomic Profiling of Breast Cancer Cell Response to Doxorubicin and TRAIL. J Proteome Res 11: 3561-3572.
28. Bernhagen J, Krohn R, Lue H, Gregory JL, Zernecke A, et al. (2007) MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment. Nature medicine 13: 587-596.
29. Brandau S, Dumitru CA, Lang S, (2012) Protumor and antitumor functions of neutrophil granulocytes. Seminars in immunopathology DOI:10.1007/s00281-012-0344-6.